跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 788 条关于
“β2-integrin”
全部
788
临床试验
452
药物
73
机构
13
资讯
250
9个月前
ImmuneWalk Therapeutics Reports Positive Phase 1 Results for IW-601, Novel Myeloid Cell Inhibitor for Inflammatory Diseases
去年
ImmuneWalk's IW-601 Shows Positive Phase 1 Results in Novel Monocyte-Targeting Approach for Inflammatory Diseases
2年前
PatientSeek Identifies Genetic Signature for Vedolizumab Response in Ulcerative Colitis
去年
Novel Oral α4β7 Integrin Inhibitor NSHO-101 Shows Promise for IBD Treatment in Phase 1 Data
去年
Alphamab Oncology Receives IND Approval for First-in-Class Bispecific ADC JSKN022 Targeting PD-L1 and Integrin αvβ6
去年
Sigvotatug Vedotin Shows Promise in NSCLC as Novel Integrin Beta-6 Targeted ADC Advances to Phase 3
6个月前
Atrogi Doses First Patients in Phase 1 Trial of Exercise-Mimicking Drug ATR-258
去年
HER2 and αVβ6 Integrin Crosstalk Drives Breast Cancer Invasion and Trastuzumab Resistance
去年
Isarna's ISTH0036 Shows Promise in Reducing Retinal Fibrosis in Phase 2 BETTER Trial
去年
Morphic Therapeutic's MORF-627 Fails to Reach Clinical Trials Due to Oncogenic Toxicity
第 1 页,共 25 页
上一页
下一页